Tiblio
Sign Up

RCM

R1 RCM Inc
NASDAQHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$6.04B
P/E Ratio
—
EPS
$-0.14
Beta
0.84
52W High
$0.00
52W Low
$0.00
50-Day MA
$14.22
200-Day MA
$13.24
Dividend Yield
—
Profit Margin
-2.48%
Forward P/E
51.55
PEG Ratio
2.06

About R1 RCM Inc

R1 RCM Inc (RCM) stands out as a leading provider of technology-driven revenue cycle management solutions, specifically designed to enhance the financial performance of healthcare organizations across the United States. Leveraging cutting-edge analytics and deep industry insights, R1 RCM optimizes billing processes and boosts operational efficiency for hospitals and outpatient facilities. By maximizing revenue capture while improving patient experiences, the company solidifies its position within a rapidly evolving healthcare landscape. With strategic initiatives aimed at expanding its service offerings and increasing market presence, R1 RCM is poised for sustained growth and a competitive edge in the increasingly complex revenue cycle management sector.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.46B
Gross Profit (TTM)$472.70M
EBITDA$518.40M
Operating Margin3.78%
Return on Equity-2.20%
Return on Assets2.35%
Revenue/Share (TTM)$5.85
Book Value$6.66
Price-to-Book2.15
Price-to-Sales (TTM)2.45
EV/Revenue3.325
EV/EBITDA19.63
Quarterly Earnings Growth (YoY)-99.30%
Quarterly Revenue Growth (YoY)14.70%
Shares Outstanding$422.39M
Float$293.71M
% Insiders1.04%
% Institutions86.91%

Historical Volatility

HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
33.7%

Volatility is currently contracting

Latest News

RCM Services Provider Fellow Health Partners Announces Strategic Investment from Cleargate Capital Partners

BAY SHORE, N.Y.--(BUSINESS WIRE)--Fellow Health Partners (“Fellow”), a leading provider of revenue cycle management ("RCM") services to physician groups, ambulatory surgery centers, and healthcare organizations nationwide, today announced that it has received a strategic investment from Cleargate Capital Partners (“Cleargate”), a healthcare-focused private equity firm committed to long-term partnerships with founder-led, lower middle market businesses. Terms of the transaction were not disclose.

Business Wire6/16/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on RCM and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

LLYEli Lilly and CompanyJNJJohnson & JohnsonABBVAbbVie IncUNHUnitedHealth Group IncorporatedMRKMerck & Company IncNVSNovartis AG ADRAZNAstraZeneca PLCNVONovo Nordisk A/STMOThermo Fisher Scientific IncAMGNAmgen IncABTAbbott LaboratoriesGILDGilead Sciences Inc
View all HEALTHCARE stocks →
Data last updated: 7/29/2026